Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age

Addiction ◽  
2013 ◽  
Vol 108 (10) ◽  
pp. 1700-1703 ◽  
Author(s):  
Paul Griffiths ◽  
Michael Evans-Brown ◽  
Roumen Sedefov

2018 ◽  
Vol 33 (3) ◽  
pp. 347-354 ◽  
Author(s):  
Eulàlia Olesti ◽  
Ilario De Toma ◽  
Johannes G Ramaekers ◽  
Tibor M Brunt ◽  
Marcel·lí Carbó ◽  
...  

Background: The unprecedented proliferation of new psychoactive substances (NPS) threatens public health and challenges drug policy. Information on NPS pharmacology and toxicity is, in most cases, unavailable or very limited and, given the large number of new compounds released on the market each year, their timely evaluation by current standards is certainly challenging. Aims: We present here a metabolomics-targeted approach to predict the pharmacological profile of NPS. Methods: We have created a machine learning algorithm employing the quantification of monoamine neurotransmitters and steroid hormones in rats to predict the similarity of new drugs to classical ones of abuse (MDMA (3,4-methyl enedioxy methamphetamine), methamphetamine, cocaine, heroin and Δ9-tetrahydrocannabinol). Results: We have characterized each classical drug of abuse and two examples of NPS (mephedrone and JWH-018) following alterations observed in the targeted metabolome profile (monoamine neurotransmitters and steroid hormones) in different brain areas, plasma and urine at 1 h and 4 h post drug/vehicle administration. As proof of concept, our model successfully predicted the pharmacological profile of a synthetic cannabinoid (JWH-018) as a cannabinoid-like drug and synthetic cathinone (mephedrone) as a MDMA-like psychostimulant. Conclusion: Our approach allows a fast NPS pharmacological classification which will benefit both drug risk evaluation policies and public health.



The Lancet ◽  
2019 ◽  
Vol 394 (10209) ◽  
pp. 1668-1684 ◽  
Author(s):  
Amy Peacock ◽  
Raimondo Bruno ◽  
Natasa Gisev ◽  
Louisa Degenhardt ◽  
Wayne Hall ◽  
...  


Author(s):  
Arnis Slesars ◽  
Aija Jermacāne

A new psychoactive substance is defined as a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions (1961, 1971), but which may pose a public health threat comparable to that posed by substances listed in these conventions. The author researched and analyzed: 1.History of new psychoactive substances in Latvia; 2.Legislative approaches for restricting new psychoactive substances in Latvia; 3.Advantages and disadvantages of criminal liability against new psychoactive substances in Latvia.





2020 ◽  
Author(s):  
Andrew David Carlo ◽  
Brian S. Barnett ◽  
Utibe R. Essien ◽  
Sandro Galea

UNSTRUCTURED In recent months, there has been a substantial focus on the spread of mis- and disinformation through the media, but there has been little mention of the public health consequences of media overconsumption and data misinterpretation. Physicians and other health professionals have an important voice and the medical field can do more to mitigate the impact of unhealthy media interaction on public health communication in the Information Age. Doing this requires a coordinated, deliberate effort. Clinicians, researchers and medical thought leaders must be cognizant of how their data and words can be rapidly shared, internalized and possibly misinterpreted through media channels. Further, medicine needs to have clear standards or guidelines for interacting with the media during public health crises, much like the mental health field has established for completed suicides of public figures. Finally, medical schools, residencies and training programs should devise clear plans to train the upcoming generation for the inevitable next pandemic or disaster.





2011 ◽  
Vol 3 (7-8) ◽  
pp. 515-523 ◽  
Author(s):  
H.R. Sumnall ◽  
M. Evans-Brown ◽  
J. McVeigh


Author(s):  
B. P Smyth

In 2010, Ireland found itself at the eye of an international storm as a network of head shops emerged selling new psychoactive substances (NPS) and Irish youth rapidly became the heaviest users of NPS in Europe. Within months, the Irish government enacted novel legislation, which has since been copied by other countries, which effectively stopped the head shops selling NPS. Critics of this policy argued that it could cause harms to escalate. A number of separate studies indicate that a range of drug-related harms increased amongst Irish youth during the period of head shop expansion. Within months of their closure, health harms began to decline. NPS-related addiction treatment episodes reduced and admissions to both psychiatric and general hospitals related to any drug problem began to fall. Population use underwent sustained decline. Consequently, the closure of head shops can be viewed as a success in terms of public health.



2005 ◽  
Vol 173 (4S) ◽  
pp. 47-47
Author(s):  
Brent K. Hollenbeck ◽  
David A. Taub ◽  
Rodney L. Dunn ◽  
John T. Wei




Sign in / Sign up

Export Citation Format

Share Document